Aggregation of activated platelets with Walker 256 carcinoma cells

Area of Science:

• Oncology
• Hematology
• Cell Biology

Background:

• Walker 256 carcinoma cells exhibit interactions with platelets.
• Platelet activation by adenosine diphosphate (ADP) or serotonin influences these interactions.
• Understanding tumor-cell platelet interactions is vital for cancer metastasis research.

Purpose of the Study:

• To investigate the interaction mechanism between Walker 256 carcinoma cells and rat platelets.
• To determine the role of platelet activation state in tumor cell aggregation.
• To elucidate the implications for in vivo metastasis.

Main Methods:

• Co-incubation of Walker 256 carcinoma cells with rat platelets activated by ADP or serotonin.
• Analysis of platelet shape change (disc-sphere transformation) as an indicator of activation.
• Experiments with spheroid washed platelets to assess aggregation without external stimuli.

Main Results:

• Walker 256 carcinoma cells formed irreversible aggregates with ADP- or serotonin-activated rat platelets.
• Partial platelet activation, indicated by shape change alone, was sufficient for tumor cell interaction.
• Spheroid washed platelets aggregated irreversibly with tumor cells without added stimuli.

Conclusions:

• Platelet activation, even partial, is key for Walker 256 carcinoma cell interaction.
• Tumor cells can interact with activated platelets in vivo, potentially via disturbed blood flow.
• Findings explain previous observations of tumor-cell platelet interactions in metastasis.